sirolimus,pazopanib
aadi biosciences,novartis
['pazopanib', 'precision 1', 'sirolimus', 'aadi bio', 'aadibio']
don't miss two nab-sirolimus posters being presented today at #asco23. the first is a company-sponsored tip update from our precision 1 phase 2 study, and the second is combination data of nab-sirolimus and pazopanib (pazo) from an ongoing investigator initiated trial. #aadibio
Aadi Bio is a precision oncology company developing therapies targeting signaling pathways in genetically-defined cancers utilizing nanoparticle delivery.